Our schistosomiasis treatment programmes specifically target school-age children and adults considered at risk, such as fishermen, living in endemic regions. In areas with very high rates of infection, entire communities may be treated through mass drug administration.
Sightsavers and partners also encourage non-drug-based practices such as water, sanitation and hygiene (WASH) initiatives.
In 2022, Sightsavers and partners helped to provide more than 7 million treatments for schistosomiasis. Since we began, we’ve also trained more than 519,000 local volunteers to distribute medication to treat a range of NTDs, including schistosomiasis.
Sightsavers researchers are working to understand how we can care for women with female genital schistosomiasis, a devastating disease that affects millions of women in Africa.
Sightsavers has been awarded $16.9 million to continue and expand its deworming work, after a funding recommendation from US charity evaluator GiveWell.
Charity evaluator GiveWell has provided a further US$7.8 million to fight intestinal worms and schistosomiasis in Nigeria and Cameroon.